Evolution Wealth Advisors, LLC Sage Therapeutics, Inc. Transaction History

Evolution Wealth Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$37.06 - $47.11 $2,223 - $2,826	-60 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$40.26 - $57.37 $3,663 - $5,220	-91 Reduced 60.26%	60 $3,000
Q2 2021 Jul 22, 2021	SELL	$54.88 - $79.29 $1,701 - $2,457	-31 Reduced 17.03%	151 $9,000
Q1 2021 Apr 20, 2021	SELL	$70.65 - $96.76 $3,249 - $4,450	-46 Reduced 20.18%	182 $14,000
Q4 2020 Feb 02, 2021	SELL	$58.41 - $89.06 $5,256 - $8,015	-90 Reduced 28.3%	228 $20,000
Q3 2020 Oct 15, 2020	BUY	$41.13 - $62.45 $13,079 - $19,859	318 New	318 $19,000
Q1 2020 Apr 22, 2020	SELL	$26.15 - $77.24 $5,334 - $15,756	-204 Closed	0 $0
Q4 2019 Feb 03, 2020	BUY	$60.18 - $154.77 $11,554 - $29,715	192 Added 1600.0%	204 $15,000
Q3 2019 Nov 12, 2019	SELL	$140.29 - $189.96 $14,449 - $19,565	-103 Reduced 89.57%	12 $2,000
Q2 2019 Jul 12, 2019	BUY	$157.85 - $183.09 $18,152 - $21,055	115 New	115 $21,000

218

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $395M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.